Ingraalys Studies on genomic and cellular plasticity during development and aging.
Ingraalys has raised $326K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2024.
Ingraalys's investors include AxLR.
Ingraalys is headquartered in Montpellier, France.
Ingraalys Studies on genomic and cellular plasticity during development and aging.
Ingraalys is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ingraalys — Funding & Investors." VCBacked, January 22, 2024, https://www.vcbacked.co/company/ingraalys. Accessed October 3, 2026.
VCBacked. (2024). Ingraalys — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/ingraalys
{{cite web |title=Ingraalys — Funding & Investors |url=https://www.vcbacked.co/company/ingraalys |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated